AIM
UTHR icon

AXA Investment Managers’s United Therapeutics UTHR Stock Holding History

AXA Investment Managers’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$17.2M Buy
+41,132
New +$13.8M 0.05% 309

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AXA Investment Managers's UTHR Position: Q3 2025 in Review

AXA Investment Managers opened a new position in United Therapeutics (UTHR) in Q3 2025: 41,132 shares worth $17.2M. The stake represents 0.05% of the portfolio and ranks #309 among its holdings.

707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • AXA Investment Managers held 41,132 shares of United Therapeutics worth $17.2M as of Q3 2025.
  • United Therapeutics was a new AXA Investment Managers position in Q3 2025.
  • United Therapeutics made up 0.05% of AXA Investment Managers's portfolio in Q3 2025, its #309 holding.
  • 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.